 |
|
A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution
Seon Mi Nam, Jee Whan Kim, Kyung Jin Eoh, Hye Min Kim, Jung Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
Obstet Gynecol Sci. 2017;60(1):39-45. Published online 2017 Jan 19 DOI: https://doi.org/10.5468/ogs.2017.60.1.39
|
|
Citations to this article as recorded by
 Sertoli–Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort
Pernille Bekker, Anne Regitze Miland-Samuelsen, Maja Patricia Smerdel, Tine Henriksen Schnack, Finn Friis Lauszus, Sven Hoedt Karstensen
International Journal of Gynecologic Cancer.2023; 33(12): 1921. CrossRef Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia
Sriram Mudraje, Sahana Shetty, Shyamala Guruvare, Ranjini Kudva
BMJ Case Reports.2022; 15(8): e249324. CrossRef Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli–Leydig Cell Tumor
Elisa De Paolis, Rosa Paragliola, Paola Concolino
Journal of Clinical Medicine.2021; 10(9): 1845. CrossRef Ovarian Sertoli–Leydig cell tumours: A systematic review of relapsed cases
James Nef, Daniela Emanuela Huber
European Journal of Obstetrics & Gynecology and Reproductive Biology.2021; 263: 261. CrossRef Characteristics and outcomes analysis of ovarian Sertoli–Leydig cell tumors (SLCTs): analysis of 15 patients
Guangning Wang, Ran Zhang, Chuan Li, Aiping Chen
Journal of Ovarian Research.2021;[Epub] CrossRef Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases
Ying Guo, Jing Wang, Yuhong Li, Yudong Wang
Archives of Gynecology and Obstetrics.2020; 302(1): 203. CrossRef Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes
Dimitrios Nasioudis, Spyridon A. Mastroyannis, Ashley F. Haggerty, Emily M. Ko, Nawar A. Latif
Archives of Gynecology and Obstetrics.2020; 302(2): 481. CrossRef Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors
Zhen Yuan, Xiao Huo, Dezhi Jiang, Mei Yu, Dongyan Cao, Huanwen Wu, Keng Shen, Jiaxin Yang, Ying Zhang, Huimei Zhou, Yao Wang
The Oncologist.2020; 25(9): e1396. CrossRef Sertoli-Leydig Cell Ovarian Tumors: Is Fertility or Endocrine-Sparing Surgery an Option upon Relapse?
Stéphanie J. Seidler, Alexandre Huber, James Nef, Daniela E. Huber
Case Reports in Oncology.2020; 13(2): 935. CrossRef Sertoli–Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature
Yasin Durmuş, Çiğdem Kılıç, Caner Çakır, Dilek Yüksel, Nurettin Boran, Alper Karalök, Gökhan Boyraz, Ahmet T. Turan
Journal of Obstetrics and Gynaecology Research.2019; 45(7): 1311. CrossRef Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors
Sebastien Gouy, Alexandra Arfi, Amandine Maulard, Patricia Pautier, Enrica Bentivegna, Alexandra Leary, Cyrus Chargari, Catherine Genestie, Philippe Morice
The Oncologist.2019; 24(5): 702. CrossRef Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors
Dimitrios Nasioudis, Theofano Orfanelli, Melissa K. Frey, Eloise Chapman-Davis, Thomas A. Caputo, Steven S. Witkin, Kevin Holcomb
Journal of Gynecologic Oncology.2019;[Epub] CrossRef Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors
Beatriz Guerreiro Ruiz Castro, Cristiano de Pádua Souza, Carlos Eduardo Mattos da Cunha Andrade, Marcelo de Andrade Vieira, Diocésio Alves Pinto de Andrade, Ricardo dos Reis
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics.2019; 41(07): 440. CrossRef
|